Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Candido E. Rivera"'
Autor:
Maymona G. Abdelmagid, Aref Al-Kali, Mark R. Litzow, Kebede H. Begna, William J. Hogan, Mirinal S. Patnaik, Shahrukh K. Hashmi, Michelle A. Elliott, Hassan Alkhateeb, Omer S. Karrar, Farah Fleti, Mohammed H. Elnayir, Candido E. Rivera, Hemant S. Murthy, James M. Foran, Mohamed A. Kharfan-Dabaja, Talha Badar, David S. Viswanatha, Kaaren K. Reichard, Naseema Gangat, Ayalew Tefferi
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract We surveyed the performance of ponatinib, as salvage therapy, in a real-world setting of chronic phase chronic myeloid leukemia (CML-CP). Among 55 consecutive patients (median age 49 years) with relapsed/refractory CML-CP, 35 (64%) had faile
Externí odkaz:
https://doaj.org/article/5713a85908654b83ae61bd72a1efa7e7
Autor:
Emily B. Wolf MD, David Li MD, Andre J. Fernandez MPAS, PA-C, Lindsay B. Gardner MD, Candido E. Rivera MD, Ewa M. Wysokinska MD, Marwan E. Shaikh MD, Han W. Tun MD, Vivek Roy MD, Muhamad Alhaj Moustafa MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 11 (2023)
Factor VII (FVII) is an important, vitamin K-dependent clotting factor. Acquired FVII deficiency is a rare entity that is associated with serious bleeding complications. We report a case of acquired FVII deficiency in a patient with recurrent chronic
Externí odkaz:
https://doaj.org/article/128a25ad03e74b48badd6609083a9599
Autor:
Susana Fortich, MD, Charles Ritchie, MD, Marwan E. Shaikh, MD, Beau Toskich, MD, Candido E. Rivera, MD, Young Erben, MD
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 7, Iss 3, Pp 524-528 (2021)
Klippel-Trenaunay syndrome (KTS) is a congenital vascular disorder characterized by the triad of cutaneous capillary malformation, lymphatic and venous anomalies, and soft tissue and bone overgrowth. Sirolimus is a mechanistic target of rapamycin inh
Externí odkaz:
https://doaj.org/article/7d48e6dbd4d14fa9ad0e977f4f02291c
Autor:
Vikas Gupta, Ruben A. Mesa, Michael W.N. Deininger, Candido E. Rivera, Shireen Sirhan, Carrie Baker Brachmann, Helen Collins, Jun Kawashima, Yan Xin, Srdan Verstovsek
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
Momelotinib, a small-molecule inhibitor of Janus kinase 1 and Janus kinase 2, has demonstrated efficacy in myelofibrosis patients with 300 mg, once-daily dosing. This open-label, non-randomized, phase 1/2 study evaluated the safety and therapeutic be
Externí odkaz:
https://doaj.org/article/dd14288ed0fb42e0b8e4c3c38537c4b5
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 7, Iss 3, Pp 524-528 (2021)
Journal of Vascular Surgery Cases and Innovative Techniques
Journal of Vascular Surgery Cases and Innovative Techniques
Klippel-Trenaunay syndrome (KTS) is a congenital vascular disorder characterized by the triad of cutaneous capillary malformation, lymphatic and venous anomalies, and soft tissue and bone overgrowth. Sirolimus is a mechanistic target of rapamycin inh
Autor:
Sonja Zweegman, Shanti Natarajan-Amé, Francesco Passamonti, Raajit K. Rampal, Moshe Talpaz, Daobin Zhou, Kelly McCaul, Mary Frances McMullin, Candido E. Rivera, Hiroshi Kawabata, Günther Gastl, H. Joachim Deeg, Heinz Gisslinger, Angela Hamblin, Vincent Ribrag, Reinier Raymakers, John Catalano, P. Mineur, Fabrizio Pane, Giuseppe Saglio, Jean Loup Demory, Josef T. Prchal, Qian Jiang, Kudrat Abdulkadyrov, Emmanuel C. Besa, Richard F. Schlenk, Gary J. Schiller, John T. Reilly, Adam J. Mead, Robert Peter Gale, William Stevenson, Gemma Buck, Kazuma Ohyashiki, Dominique Bordessoule, Mark Drummond, Jianyong Li, Ayalew Tefferi, Ting Liu, Tomoko Hata, Jianhua Zhong, Juan Carlos Hernandez Boluda, Damiano Rondelli, Norio Komatsu, John Mascarenhas, Zhixiang Shen, Timothy Devos, Alessandro M. Vannucchi, Katsuto Takenaka, Randall Brown, Haifa K. Al-Ali, Thomas J. Nevill, Jen Chin Wang, Daniel Tesfa, Jennifer O'Sullivan, Andrew Turner, Guanlin Wang, Galina Salogub, Claire N. Harrison, Dragana Milojkovic, Giovanni Barosi, James W. Vardiman, Peter A. W. te Boekhorst, Ruben A. Mesa, Jan Van Droogenbroeck, Manana Sokolova, Vikas Gupta, Lennart Nilsson, Andrey Zaritskiy, Nikolaos Barkas, Werner Linkesch, Mario Cazzola, Jean-Jacques Kiladjian, Ramon V. Tiu, Kiyoshi Ando, Onima Chowdhury, Emilio Ojeda, Martin Griesshammer, Christian Recher, Alessandro Rambaldi, Francisco Cervantes, Giorgina Specchia
Publikováno v:
Leukemia
for the RESUME trialists 2020, ' Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide ', Leukemia . https://doi.org/10.1038/s41375-020-0979-6, https://doi.org/10.1038/s41375-020-0979-6
Chowdhury, O, O’Sullivan, J, Barkas, N, Wang, G, Buck, G, Hamblin, A, Tefferi, A, Al-Ali, H K, Barosi, G, Devos, T, Gisslinger, H, Jiang, Q, Kiladjian, J J, Mesa, R, Passamonti, F, Ribrag, V, Schiller, G, Vannucchi, A M, Zhou, D, McMullin, M F, Zhong, J, Gale, R P, Mead, A J, Catalano, J, Stevenson, W, Gastl, G, Linkesch, W, Van Droogenbroeck, J, Mineur, P, Gupta, V, Turner, A, Nevill, T, Li, J, Shen, Z, Liu, T, Bordessoule, D, Natarajan-Amé, S, Recher, C, Demory, J L, Schlenk, R, Griesshammer, M, Cazzola, M, Saglio, G, Specchia, G, Rambaldi, A, Pane, F, Zweegman, S, te Boekhorst, P, Raymakers, R, Abdulkadyrov, K, Sokolova, M, Salogub, G, Zaritskiy, A, Cervantes, F, Boluda, J C H, Ojeda, E, Tesfa, D, Nilsson, L, Drummond, M, Reilly, J, Harrison, C, Milojkovic, D, Rivera, C, Besa, E, Deeg, H J, Mascarenhas, J, Prchal, J, Tiu, R, Talpaz, M, Wang, J C, Rampal, R, Rondelli, D, McCaul, K, Brown, R, Komatsu, N, Ohyashiki, K, Ando, K, Kawabata, H, Takenaka, K, Hata, T, Vardiman, J & for the RESUME trialists 2021, ' Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide ', Leukemia, vol. 35, no. 4, pp. 1197-1202 . https://doi.org/10.1038/s41375-020-0979-6
Leukemia, 35(4), 1197-1202. Nature Publishing Group
for the RESUME trialists 2020, ' Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide ', Leukemia . https://doi.org/10.1038/s41375-020-0979-6, https://doi.org/10.1038/s41375-020-0979-6
Chowdhury, O, O’Sullivan, J, Barkas, N, Wang, G, Buck, G, Hamblin, A, Tefferi, A, Al-Ali, H K, Barosi, G, Devos, T, Gisslinger, H, Jiang, Q, Kiladjian, J J, Mesa, R, Passamonti, F, Ribrag, V, Schiller, G, Vannucchi, A M, Zhou, D, McMullin, M F, Zhong, J, Gale, R P, Mead, A J, Catalano, J, Stevenson, W, Gastl, G, Linkesch, W, Van Droogenbroeck, J, Mineur, P, Gupta, V, Turner, A, Nevill, T, Li, J, Shen, Z, Liu, T, Bordessoule, D, Natarajan-Amé, S, Recher, C, Demory, J L, Schlenk, R, Griesshammer, M, Cazzola, M, Saglio, G, Specchia, G, Rambaldi, A, Pane, F, Zweegman, S, te Boekhorst, P, Raymakers, R, Abdulkadyrov, K, Sokolova, M, Salogub, G, Zaritskiy, A, Cervantes, F, Boluda, J C H, Ojeda, E, Tesfa, D, Nilsson, L, Drummond, M, Reilly, J, Harrison, C, Milojkovic, D, Rivera, C, Besa, E, Deeg, H J, Mascarenhas, J, Prchal, J, Tiu, R, Talpaz, M, Wang, J C, Rampal, R, Rondelli, D, McCaul, K, Brown, R, Komatsu, N, Ohyashiki, K, Ando, K, Kawabata, H, Takenaka, K, Hata, T, Vardiman, J & for the RESUME trialists 2021, ' Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide ', Leukemia, vol. 35, no. 4, pp. 1197-1202 . https://doi.org/10.1038/s41375-020-0979-6
Leukemia, 35(4), 1197-1202. Nature Publishing Group
Drug-induced thrombocytopenia (DITP) is commonly attributed to antimicrobial agents; 153 drugs are believed to have a high probability of causing immune-mediated thrombocytopenia. Rifampin is categorized as a definite cause of DITP. Median time to pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::750ea428fcb36c46f2d2a28b7e8b3320
https://doi.org/10.1093/med/9780190052973.003.0030
https://doi.org/10.1093/med/9780190052973.003.0030
Autor:
Andrea Rivero, Jason Siegel, David Abia-Trujillo, Lisa Brumble, J O’brein Jennifer, Torp Klaus, Megan Melody, Siva Naga S. Yarrarapu, Austin Cusick, Pramod Guru, Pankaj Bansal, Candido E. Rivera, Pablo Moreno Franco, Christan Santos, Augustine S. Lee, Tara J. Brigham, Varun Moktan, Claudia R. Libertin, Devang Sanghavi
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 15 (2021)
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Introduction In the unprecedented era of COVID-19, ongoing research and evolution of evidence has led to ever-changing guidelines for clinical monitoring and therapeutic options. Formulating treatment protocols requires the understanding and applicat
Autor:
Ashish V. Chintakuntlawar, Lisa A. Kottschade, Alexandra Higgins, Ronald S. Go, Anna Schwecke, Uma Thanarajasingam, Paul J. Hampel, Yiyi Yan, Antoine N. Saliba, Lionel A. Kankeu Fonkoua, Harry E Fuentes-Bayne, Anuhya Kommalapati, Xavier Andrade-Gonzalez, Evandro D. Bezerra, Aref Al-Kali, Alexandra P. Wolanskyj-Spinner, Yanyan Lou, Gita Thanarajasingam, Sagar Rakshit, Candido E. Rivera, Matthew S. Block, Katharine A. Price, Zhuoer Xie, Ariela L. Marshall, Daniel S. Childs
Publikováno v:
American Journal of Hematology. 96
Autor:
Alessia Castellino, Candido E. Rivera, Grzegorz S. Nowakowski, Michele Spina, Angela Congiu, Giovannino Ciccone, T. E. Witzig, Alessandra Tucci, A. L. Molinari, Craig B. Reeder, Giorgio Inghirami, Stephen M. Ansell, Thomas M. Habermann, William R. Macon, Rebecca L. King, Gianluca Gaidano, Annalisa Chiappella, James M. Foran, Vincenzo Pavone, Umberto Vitolo, Betsy LaPlant, Levy D. Pederson, Federica Cavallo
Publikováno v:
Blood Cancer Journal, Vol 8, Iss 11, Pp 1-8 (2018)
Blood Cancer Journal
Blood Cancer Journal
Lenalidomide-RCHOP (R2-CHOP21) has been shown to be safe and effective in patients with untreated diffuse large B-cell lymphoma (DLBCL). The aim of this analysis is to report long-term outcome and toxicities in newly diagnosed DLBCL patients who rece